Clinical Recommendations 2017 Hypertension Clinical Practice Guidelines4 Recommendation for Performance Measures (Guideline Section 12.4.1) Use of performance measures in combination with other quality improvement strategies at patient-, provider-, and system-based levels is reasonable to facilitate optimal hypertension control.56,227,228 (Class 2a, Level of Evidence: B-NR) ACC indicates American College of Cardiology; AHA, American Heart Association; CDU, care delivery unit; HBP, high blood pressure; and RCT, randomized controlled trial. Appendix A. Continued 46 Appendix B. Author Listing of Relationships With Industry and Other Entities (Relevant) 2019 AHA/ACC Clinical Performance and Quality Measures for Adults With High Blood Pressure Committee Member Employment Consultant Speakers Bureau Ownership/ Partnership/ Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Donald E. Casey Jr, Chair Thomas Jefferson College of Population Health Adjunct Faculty; Rush Medical College Faculty; University of Minnesota, Institute of Health Informatics Affiliate Faculty; President, American College of Medical Quality; IPO 4 Health Principal and Founder None None None None None None Randal J. Thomas, Vice Chair Mayo Clinic Medical Director, Cardiac Rehabilitation Program None None None None None None Vivek Bhalla Stanford University Medical Center Assistant Professor of Medicine, Nephrology; Stanford Hypertension Center Director Relypsa, Inc. None None None PyrAmes Health None Yvonne Commodore- Mensah Johns Hopkins School of Nursing Assistant Professor None None None None None None Paul A. Heidenreich Stanford VA Palo Alto Health Care System Professor of Medicine None None None None None None Dhaval Kolte Massachusetts General Hospital and Harvard Medical School International Cardiology Fellow None None None None None None Paul Muntner University of Alabama at Birmingham Professor, Department of Epidemiology None None None None None None Sidney C. Smith Jr University of North Carolina at Chapel Hill Professor of Medicine; Division of Cardiology, Department of Medicine None None None None None None John A. Spertus Washington University School of Medicine in St. Louis Adjunct Professor of Medicine, Cardiovascular Division; Saint Luke s Mid America Heart Institute Director, Health Outcomes Research; University of Missouri-Kansas City Professor, Daniel J. Lauer Missouri Endowed Chair in Metabolism and Vascular Disease Research AstraZeneca* Bayer Healthcare Pharmaceuticals Boehringer Ingelheim* Janssen* Novartis* None None None AstraZeneca UK Limited Novartis* None John R. Windle University of Nebraska College of Medicine Professor, Internal Medicine, Division of Cardiovascular Medicine None None None None None None Gregory D. Wozniak American Medical Association Director, Outcomes Analytics; Northwestern University, Feinberg School of Medicine Adjunct Assistant Professor None None None None None None Boback Ziaeian UCLA David Geffen School of Medicine Assistant Professor; US Department of Veterans Affairs Assistant Professor None None None None None None This table represents the relationships of committee members with industry and other entities that were determined to be relevant to this document. 